Serial Number | 90628728 |
Word Mark | QUALLENT PHARMACEUTICALS |
Filing Date | Wednesday, April 7, 2021 |
Status | 700 - REGISTERED |
Status Date | Tuesday, March 7, 2023 |
Registration Number | 6997500 |
Registration Date | Tuesday, March 7, 2023 |
Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, May 24, 2022 |
Goods and Services | Pharmaceutical preparations for use in treating human diseases, namely, the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hematological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; nutraceuticals for use as human dietary supplements; and health food supplements for use in treating human dietary deficiencies |
Goods and Services | Wholesale distributorship services featuring pharmaceutical preparations for use in treating human diseases |
Disclaimer with Predetermined Text | "PHARMACEUTICALS" |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, July 14, 2021 |
Primary Code | 005 |
First Use Anywhere Date | Monday, November 15, 2021 |
First Use In Commerce Date | Monday, November 15, 2021 |
International Class | 035 - Advertising; business management; business administration; office functions. |
US Class Codes | 100, 101, 102 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, July 14, 2021 |
Primary Code | 035 |
First Use Anywhere Date | Monday, November 15, 2021 |
First Use In Commerce Date | Monday, November 15, 2021 |
Party Name | Express Scripts Strategic Development, Inc. |
Party Type | 30 - Original Registrant |
Legal Entity Type | 03 - Corporation |
Address | St. Louis, MO 63121 |
Party Name | Express Scripts Strategic Development, Inc. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | St. Louis, MO 63121 |
Party Name | Express Scripts Strategic Development, Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | St. Louis, MO 63121 |
Event Date | Event Description |
Tuesday, March 7, 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
Tuesday, March 7, 2023 | REGISTERED-PRINCIPAL REGISTER |
Thursday, February 2, 2023 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
Wednesday, February 1, 2023 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
Thursday, January 19, 2023 | TEAS EXTENSION RECEIVED |
Thursday, January 19, 2023 | STATEMENT OF USE PROCESSING COMPLETE |
Thursday, December 15, 2022 | USE AMENDMENT FILED |
Thursday, January 19, 2023 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
Thursday, December 15, 2022 | TEAS STATEMENT OF USE RECEIVED |
Tuesday, July 19, 2022 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Tuesday, May 24, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, May 24, 2022 | PUBLISHED FOR OPPOSITION |
Wednesday, May 4, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, April 19, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Thursday, April 14, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Thursday, April 14, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Thursday, April 14, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Monday, November 15, 2021 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Monday, November 15, 2021 | NON-FINAL ACTION E-MAILED |
Monday, November 15, 2021 | NON-FINAL ACTION WRITTEN |
Wednesday, November 3, 2021 | ASSIGNED TO EXAMINER |
Wednesday, July 14, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Saturday, April 10, 2021 | NEW APPLICATION ENTERED |